AAAAAA

   
Results: 1-16 |
Results: 16
URSODEOXYCHOLIC ACID THERAPY FOR PRIMARY SCLEROSING CHOLANGITIS - RESULTS OF A 2-YEAR RANDOMIZED CONTROLLED TRIAL TO EVALUATE SINGLE VERSUSMULTIPLE DAILY DOSES
Authors: VANHOOGSTRATEN HJF WOLFHAGEN FHJ VANDEMEEBERG PC KUIPER H NIX GAJJ BECX MCJM HOEK AC VANHOUTE DPF RIJK MCM SALEMANS JMJI SCHERPENISSE J SCHRIJVER M SMIT AM SPOELSTRA P STADHOUDERS PHGM TAN TG HOP WCJ TENKATE FJW VANBERGEHENEGOUWEN GP SCHALM SW VANBUUREN HR
Citation: Hjf. Vanhoogstraten et al., URSODEOXYCHOLIC ACID THERAPY FOR PRIMARY SCLEROSING CHOLANGITIS - RESULTS OF A 2-YEAR RANDOMIZED CONTROLLED TRIAL TO EVALUATE SINGLE VERSUSMULTIPLE DAILY DOSES, Journal of hepatology, 29(3), 1998, pp. 417-423
URSODEOXYCHOLIC ACID (UDCA) FOR PRIMARY SCLEROSING CHOLANGITIS (PSC) - RESULTS OF A 2-YEAR RANDOMIZED CONTROLLED TRIAL EVALUATING SINGLE VERSUS MULTIPLE DAILY DOSES
Authors: VANHOOGSTRATEN HJF VANDEMEEBERG PC WOLFHAGEN FHJ KUIPER H HOP WCJ VANBERGEHENEGOUWEN GP SCHALM SW VANBUUREN HR
Citation: Hjf. Vanhoogstraten et al., URSODEOXYCHOLIC ACID (UDCA) FOR PRIMARY SCLEROSING CHOLANGITIS (PSC) - RESULTS OF A 2-YEAR RANDOMIZED CONTROLLED TRIAL EVALUATING SINGLE VERSUS MULTIPLE DAILY DOSES, Hepatology, 26(4), 1997, pp. 1089-1089
LOW-DOSE VERSUS HIGH-DOSE URSODEOXYCHOLIC ACID IN CYSTIC FIBROSIS-RELATED CHOLESTATIC LIVER-DISEASE - RESULTS OF A RANDOMIZED STUDY WITH 1-YEAR FOLLOW-UP
Authors: VANDEMEEBERG PC HOUWEN RHJ SINAASAPPEL M HEIJERMAN HGM BIJLEVELD CMA VANBERGEHENEGOUWEN GP
Citation: Pc. Vandemeeberg et al., LOW-DOSE VERSUS HIGH-DOSE URSODEOXYCHOLIC ACID IN CYSTIC FIBROSIS-RELATED CHOLESTATIC LIVER-DISEASE - RESULTS OF A RANDOMIZED STUDY WITH 1-YEAR FOLLOW-UP, Scandinavian journal of gastroenterology, 32(4), 1997, pp. 369-373
APOLIPOPROTEIN E4 GENOTYPE AND GALLBLADDER MOTILITY INFLUENCE SPEED OF GALLSTONE CLEARANCE AND RISK OF RECURRENCE AFTER EXTRACORPOREAL SHOCK-WAVE LITHOTRIPSY
Authors: PORTINCASA P VANERPECUM KJ VANDEMEEBERG PC DALLINGATHIE GM DEBRUIN TWA VANBERGEHENEGOUWEN GP
Citation: P. Portincasa et al., APOLIPOPROTEIN E4 GENOTYPE AND GALLBLADDER MOTILITY INFLUENCE SPEED OF GALLSTONE CLEARANCE AND RISK OF RECURRENCE AFTER EXTRACORPOREAL SHOCK-WAVE LITHOTRIPSY, Hepatology, 24(3), 1996, pp. 580-587
SINGLE OR MULTIPLE-DOSE URSODEOXYCHOLIC ACID FOR CHOLESTATIC LIVER-DISEASE - BILIARY ENRICHMENT AND BIOCHEMICAL RESPONSE
Authors: VANDEMEEBERG PC WOLFHAGEN FHJ VANBERGEHENEGOUWEN GP SALEMANS JMJI TANGERMAN A VANBUUREN HR VANHATTUM J VANERPECUM KJ
Citation: Pc. Vandemeeberg et al., SINGLE OR MULTIPLE-DOSE URSODEOXYCHOLIC ACID FOR CHOLESTATIC LIVER-DISEASE - BILIARY ENRICHMENT AND BIOCHEMICAL RESPONSE, Journal of hepatology, 25(6), 1996, pp. 887-894
INCREASED GALL-BLADDER VOLUME IN PRIMARY SCLEROSING CHOLANGITIS
Authors: VANDEMEEBERG PC PORTINCASA P WOLFHAGEN FHJ VANERPECUM KJ VANBERGEHENEGOUWEN GP
Citation: Pc. Vandemeeberg et al., INCREASED GALL-BLADDER VOLUME IN PRIMARY SCLEROSING CHOLANGITIS, Gut, 39(4), 1996, pp. 594-599
RISK OF PRIMARY SCLEROSING CHOLANGITIS IS ASSOCIATED WITH NONSMOKING BEHAVIOR
Authors: VANERPECUM KJ SMITS SJHM VANDEMEEBERG PC LINN FHH WOLFHAGEN FHJ VANBERGEHENEGOUWEN GP ALGRA A
Citation: Kj. Vanerpecum et al., RISK OF PRIMARY SCLEROSING CHOLANGITIS IS ASSOCIATED WITH NONSMOKING BEHAVIOR, Gastroenterology, 110(5), 1996, pp. 1503-1506
GALLBLADDER (GB) EMPTYING IN-VIVO AND CONTRACTILITY IN-VITRO OF GALLSTONE PATIENTS ON URSODEOXYCHOLIC ACID (UDCA)
Authors: VANDEMEEBERG PC PORTINCASA P VANDEHEIJNING BJM VANERPECUM KJ AKKERMANS LMA HENEGOUWEN GPV
Citation: Pc. Vandemeeberg et al., GALLBLADDER (GB) EMPTYING IN-VIVO AND CONTRACTILITY IN-VITRO OF GALLSTONE PATIENTS ON URSODEOXYCHOLIC ACID (UDCA), Gastroenterology, 110(4), 1996, pp. 774-774
SINGLE VERSUS 3 TIMES DAILY URSODEOXYCHOLIC ACID (UDCA) FOR PRIMARY SCLEROSING CHOLANGITIS (PSC) - RESULTS OF A RANDOMIZED CONTROLLED TRIAL
Authors: VANHOOGSTRATEN HJF WOLFHAGEN FJH VANDEMEEBERG PC VANBUUREN HR HENEGOUWEN GPB SCHALM SW
Citation: Hjf. Vanhoogstraten et al., SINGLE VERSUS 3 TIMES DAILY URSODEOXYCHOLIC ACID (UDCA) FOR PRIMARY SCLEROSING CHOLANGITIS (PSC) - RESULTS OF A RANDOMIZED CONTROLLED TRIAL, Gastroenterology, 110(4), 1996, pp. 1352-1352
CHOLESTATIC LIVER-DISEASES - NEW STRATEGIES FOR PREVENTION AND TREATMENT OF HEPATOBILIARY AND CHOLESTATIC DISEASES
Authors: VANDEMEEBERG PC WOLFHAGEN FHJ VANERPECUM KJ HENEGOUWEN GPV
Citation: Pc. Vandemeeberg et al., CHOLESTATIC LIVER-DISEASES - NEW STRATEGIES FOR PREVENTION AND TREATMENT OF HEPATOBILIARY AND CHOLESTATIC DISEASES, Netherlands journal of medicine, 47(1), 1995, pp. 30-35
MARKED EFFECTS OF ACUTE BUT NOT CHRONIC ORAL CHOLESTYRAMINE (CH) ON GALLBLADDER (GB) AND ANTRODUODENAL MOTILITY
Authors: PORTINCASA P VANDEMEEBERG PC VANERPECUM KJ SMOUTH AJPM AKKERMANS LMA PALASICANO G VANBERGEHENEGOUWEN GP
Citation: P. Portincasa et al., MARKED EFFECTS OF ACUTE BUT NOT CHRONIC ORAL CHOLESTYRAMINE (CH) ON GALLBLADDER (GB) AND ANTRODUODENAL MOTILITY, Gastroenterology, 108(4), 1995, pp. 432-432
SINGLE-DOSE OR MULTIPLE DOSES OF URSODEOXYCHOLIC ACID (UDCA) ARE EQUALLY EFFECTIVE IN THE TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS (PSC)AND PRIMARY BILIARY-CIRRHOSIS (PBC)
Authors: VANDEMEEBERG PC WOLFHAGEN FHJ VANERPECUM KJ SALEMANS JMJI SCHALM SW VANBERGEHENEGOUWEN GP
Citation: Pc. Vandemeeberg et al., SINGLE-DOSE OR MULTIPLE DOSES OF URSODEOXYCHOLIC ACID (UDCA) ARE EQUALLY EFFECTIVE IN THE TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS (PSC)AND PRIMARY BILIARY-CIRRHOSIS (PBC), Gastroenterology, 108(4), 1995, pp. 1191-1191
LARGE FASTING GALLBLADDER VOLUME (GBV) IN PRIMARY SCLEROSING CHOLANGITIS (PSC), A DIAGNOSTIC-TOOL
Authors: VANDEMEEBERG PC PORTINCASA P WOLFHAGEN FHJ VANERPECUM KJ VANBERGEHENEGOUWEN GP
Citation: Pc. Vandemeeberg et al., LARGE FASTING GALLBLADDER VOLUME (GBV) IN PRIMARY SCLEROSING CHOLANGITIS (PSC), A DIAGNOSTIC-TOOL, Gastroenterology, 108(4), 1995, pp. 1191-1191
ANTRO-DUODENAL AND GALLBLADDER (GB) MOTILITY IN PRIMARY SCLEROSING CHOLANGITIS (PSC) - EFFECTS OF URSODEOXYCHOLIC ACID (UDCA)
Authors: VANDEMEEBERG PC VANERPECUM KJ SAMSOM M STOLK MFJ PORTINCASA P AKKERMANS LMA SMOUT AJPM VANBERGEHENEGOUWEN GP
Citation: Pc. Vandemeeberg et al., ANTRO-DUODENAL AND GALLBLADDER (GB) MOTILITY IN PRIMARY SCLEROSING CHOLANGITIS (PSC) - EFFECTS OF URSODEOXYCHOLIC ACID (UDCA), Gastroenterology, 106(4), 1994, pp. 10001001-10001001
RATIONALE FOR THERAPY WITH URSODEOXYCHOLIC ACID IN PATIENTS WITH CHOLESTATIC LIVER-DISEASE
Authors: VANERPECUM KJ VANDEMEEBERG PC HENEGOUWEN GPV
Citation: Kj. Vanerpecum et al., RATIONALE FOR THERAPY WITH URSODEOXYCHOLIC ACID IN PATIENTS WITH CHOLESTATIC LIVER-DISEASE, Netherlands journal of medicine, 43(5-6), 1993, pp. 233-238
THERAPY WITH URSODEOXYCHOLIC ACID IN CHOLESTATIC LIVER-DISEASE
Authors: VANDEMEEBERG PC VANERPECUM KJ VANBERGEHENEGOUWEN GP
Citation: Pc. Vandemeeberg et al., THERAPY WITH URSODEOXYCHOLIC ACID IN CHOLESTATIC LIVER-DISEASE, Scandinavian journal of gastroenterology, 28, 1993, pp. 15-20
Risultati: 1-16 |